Adam Waldman
Corporate Officer/Principal en TG THERAPEUTICS, INC. .
Perfil
Adam Waldman is currently the Chief Commercial Officer at TG Therapeutics, Inc. He previously worked at Celgene Corp.
as the Head of Haematology & Oncology Marketing.
Waldman received an undergraduate degree from Rutgers State University of New Jersey and an MBA from the University of Rochester Simon Business School.
Cargos activos de Adam Waldman
| Empresas | Cargo | Inicio |
|---|---|---|
| TG THERAPEUTICS, INC. | Corporate Officer/Principal | 04/06/2018 |
Antiguos cargos conocidos de Adam Waldman.
| Empresas | Cargo | Fin |
|---|---|---|
| CELGENE | Corporate Officer/Principal | - |
Formación de Adam Waldman.
| Rutgers State University of New Jersey | Undergraduate Degree |
| University of Rochester Simon Business School | Masters Business Admin |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| TG THERAPEUTICS, INC. | Health Technology |
| Empresas privadas | 1 |
|---|---|
Celgene Corp.
 Celgene Corp. BiotechnologyHealth Technology Celgene Corp. is an integrated global biopharmaceutical company, which engages in the discovery, development and commercialization of therapies for the treatment of cancer and inflammatory diseases. Its primary commercial stage products include Revlimid, Pomalyst, Imnovid, Otezla, Abraxane, and Vidaza. The company was founded by David Stirling and Sol Barer in 1986 and is headquartered in Summit, NJ. | Health Technology |
- Bolsa de valores
- Insiders
- Adam Waldman
